Interaction of aurovertin with submitochondrial particles, deficient in ATPase inhibitor.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors*; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001665:Binding Sites; D004735:Energy Transfer; D007700:Kinetics; D008931:Mitochondria, Muscle / Q000187:drug effects / Q000378:metabolism*; D003904:Mitosporic Fungi; D008954:Models, Biological; D008968:Molecular Conformation; D009206:Myocardium; D009840:Oligomycins / Q000494:pharmacology; D009940:Organoids / Q000187:drug effects / Q000378:metabolism; D010710:Phosphates / Q000494:pharmacology; D011789:Quantum Theory; D011955:Receptors, Drug; D013050:Spectrometry, Fluorescence; D013056:Spectrophotometry, Ultraviolet; D013997:Time Factors
D000900:Anti-Bacterial Agents; D009840:Oligomycins; D010710:Phosphates; D011955:Receptors, Drug; D000244:Adenosine Diphosphate; D000255:Adenosine Triphosphate; D000251:Adenosine Triphosphatases